Carbidopa and levodopa
Carbidopa and Levodopa Tablets, USP
Approved
Approval ID
bce46b86-5ad8-4375-b04d-b25ce488ae29
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 12, 2023
Manufacturers
FDA
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Carbidopa and levodopa
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code50090-3419
Application NumberANDA074260
Product Classification
M
Marketing Category
C73584
G
Generic Name
Carbidopa and levodopa
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 30, 2020
FDA Product Classification
INGREDIENTS (7)
CARBIDOPAActive
Quantity: 25 mg in 1 1
Code: MNX7R8C5VO
Classification: ACTIM
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
D&C YELLOW NO. 10 ALUMINUM LAKEInactive
Code: CQ3XH3DET6
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
LEVODOPAActive
Quantity: 100 mg in 1 1
Code: 46627O600J
Classification: ACTIB